Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OBIO compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name
OBIO
Orchestra BioMed Holdings, Inc.
Change
Mkt cap
Revenue
Revenue
SYK
Stryker Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
OBIO
Orchestra BioMed Holdings, Inc.
vs
SYK
Stryker Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OBIO, solid
SYK, dashed
Supply-chain overlap
Revenue flow
OBIO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OBIO
9
MDT
Medtronic, Inc. (an affiliate of Medtronic plc) ("Medtronic")
supplier
SANM
Sanmina
supplier
LGND
Ligand Pharmaceuticals Incorporated ("Ligand")
customer
ITGR
Integer Holdings Corporation ("Integer")
supplier
5 more · OBIO chain
›
Shared
0
No shared counterparties.
Only SYK
1
UFPT
UFP Technologies
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
OBIO
Orchestra BioMed Holdings, Inc.
Change
5.64
▼
−6.05%
· post 4.92
Mkt cap
$337.8M
Revenue
$88,000
Q2 FY26
Revenue
$33M
FY25
SYK
Stryker Corp
Change
333.92
▼
−1.69%
· post 334.98
Closed
Nov 5 '26
Mkt cap
$127.6B
Revenue
$6.5B
Q3 FY26
Revenue
$25.1B
FY25
vs
Compare
Closed
Nov 5 '26
OBIO
Orchestra BioMed Holdings, Inc.
vs
SYK
Stryker Corp
5.64
▼
−6.05%
post 4.92
Price
333.92
▼
−1.69%
post 334.98
$337.8M
Mkt cap
$127.6B
Q2 FY26
$88,000
Revenue
$6.5B
Q3 FY26
FY25
$33M
Revenue
$25.1B
FY25
Change
Change
OBIO
5.64
▼
−6.05%
vs
SYK
333.92
▼
−1.69%
Closed
Nov 5 '26